Mary Mosher

Array ( [id] => 7270576 [patent_doc_number] => 20040059094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Hapten-carrier conjugates and uses thereof' [patent_app_type] => new [patent_app_number] => 10/622064 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34941 [patent_no_of_claims] => 115 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20040059094.pdf [firstpage_image] =>[orig_patent_app_number] => 10622064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623447 [patent_doc_number] => 07138252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Molecular antigen arrays' [patent_app_type] => utility [patent_app_number] => 10/617876 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 40452 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138252.pdf [firstpage_image] =>[orig_patent_app_number] => 10617876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865457 [patent_doc_number] => 20060099587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Alphavirus vectors having attentuated virion structural proteins' [patent_app_type] => utility [patent_app_number] => 10/517083 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15722 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099587.pdf [firstpage_image] =>[orig_patent_app_number] => 10517083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 709609 [patent_doc_number] => 07056507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Adsorbent for eliminating hepatitis C virus, adsorber, and adsorption method' [patent_app_type] => utility [patent_app_number] => 10/458297 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7212 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056507.pdf [firstpage_image] =>[orig_patent_app_number] => 10458297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363917 [patent_doc_number] => 20040005551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Circulating epstein-barr virus DNA in the serum or plasma of patients for the prediction and detection of epstein-barr virus associated cancers apart from head, neck and lymphoid malignancies' [patent_app_type] => new [patent_app_number] => 10/455042 [patent_app_country] => US [patent_app_date] => 2003-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4316 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005551.pdf [firstpage_image] =>[orig_patent_app_number] => 10455042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 648695 [patent_doc_number] => 07115270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Smallpox vaccine' [patent_app_type] => utility [patent_app_number] => 10/445671 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4309 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115270.pdf [firstpage_image] =>[orig_patent_app_number] => 10445671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793111 [patent_doc_number] => 06982156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-03 [patent_title] => 'Compositions and methods modulating variola and vaccinia virus' [patent_app_type] => utility [patent_app_number] => 10/441624 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 11465 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982156.pdf [firstpage_image] =>[orig_patent_app_number] => 10441624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6663662 [patent_doc_number] => 20030202988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Modified vaccinia ankara virus variant' [patent_app_type] => new [patent_app_number] => 10/439953 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13742 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20030202988.pdf [firstpage_image] =>[orig_patent_app_number] => 10439953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 996313 [patent_doc_number] => 06913752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-05 [patent_title] => 'Modified Vaccinia Ankara virus variant' [patent_app_type] => utility [patent_app_number] => 10/439439 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 13886 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/913/06913752.pdf [firstpage_image] =>[orig_patent_app_number] => 10439439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865559 [patent_doc_number] => 20030191085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Topical delivery of vaccines' [patent_app_type] => new [patent_app_number] => 10/436757 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3594 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191085.pdf [firstpage_image] =>[orig_patent_app_number] => 10436757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367031 [patent_doc_number] => 20040006001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Ferritin fusion proteins for use in vaccines and other applications' [patent_app_type] => new [patent_app_number] => 10/435666 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10198 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006001.pdf [firstpage_image] =>[orig_patent_app_number] => 10435666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236430 [patent_doc_number] => 20070128587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Method of diagnosis of foot and mouth disease and the diagnostic kit' [patent_app_type] => utility [patent_app_number] => 10/555059 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9907 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128587.pdf [firstpage_image] =>[orig_patent_app_number] => 10555059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725524 [patent_doc_number] => 20030207836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry' [patent_app_type] => new [patent_app_number] => 10/429735 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8171 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207836.pdf [firstpage_image] =>[orig_patent_app_number] => 10429735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664143 [patent_doc_number] => 20030203469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Efficient purification of adenovirus' [patent_app_type] => new [patent_app_number] => 10/429303 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6010 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203469.pdf [firstpage_image] =>[orig_patent_app_number] => 10429303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 612455 [patent_doc_number] => 07147849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-12 [patent_title] => 'Pharmaceutical formulation' [patent_app_type] => utility [patent_app_number] => 10/429256 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 888 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/147/07147849.pdf [firstpage_image] =>[orig_patent_app_number] => 10429256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 736540 [patent_doc_number] => 07033751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Antigenic fragment of human T-lymphotropic virus' [patent_app_type] => utility [patent_app_number] => 10/423156 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 4611 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033751.pdf [firstpage_image] =>[orig_patent_app_number] => 10423156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701138 [patent_doc_number] => 20030224018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Modified Vaccinia Virus Ankara for the vaccination of neonates' [patent_app_type] => new [patent_app_number] => 10/418854 [patent_app_country] => US [patent_app_date] => 2003-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13705 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224018.pdf [firstpage_image] =>[orig_patent_app_number] => 10418854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275496 [patent_doc_number] => 20040234947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Cells for detection of influenza and parainfluenza viruses' [patent_app_type] => new [patent_app_number] => 10/474759 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11950 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234947.pdf [firstpage_image] =>[orig_patent_app_number] => 10474759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1199390 [patent_doc_number] => 06723329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'Use of parapox B2L protein to modify immune responses to administered antigens' [patent_app_type] => B2 [patent_app_number] => 10/414759 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4104 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723329.pdf [firstpage_image] =>[orig_patent_app_number] => 10414759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874440 [patent_doc_number] => 20030194737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Use of parapox B2L protein to modify immune responses to administered antigens' [patent_app_type] => new [patent_app_number] => 10/414609 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4111 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194737.pdf [firstpage_image] =>[orig_patent_app_number] => 10414609 [rel_patent_id] =>[rel_patent_doc_number] =>)